Earnings

DXC Selling Insurance Business: What Q2 Results Show

DXC's Q2 fiscal 2027 report confirmed talks to sell its insurance business and showed the unit's revenue up 23.1% on a one-time contract modification. Without insurance, Q2 revenue fell 7.1% and segment profit fell 28.5%.

DXC Selling Insurance Business: What Q2 Results Show

DXC Technology ($DXC) is in talks to sell its insurance business but has not signed a deal, and its October 29 Q2 fiscal 2027 report says so directly: "DXC acknowledges ongoing discussions regarding a possible sale of its insurance business." The same report showed insurance revenue up 23.1% to $394 million, helped by a one-time contract modification. Total revenue fell 4.0% to $3.03 billion, and DXC cut its full-year revenue guide to $11.91 billion to $11.98 billion.

The quarter answers a narrower question than the deal headlines: what is DXC selling, and what would be left? Here is what the Q2 press release, the 10-Q and the call actually said.

The deal talks in one paragraph

Reuters reported on October 19, 2026 that DXC was in advanced talks to sell its Insurance Software & Services unit to Eldridge Industries for about $2.4 billion. The sources said a deal could come within weeks but was not certain. No definitive agreement had been announced through the November 10 close. The buyer, the price math and the stock's reaction are covered in TTFY's breakdown of the $2.4 billion Eldridge talks.

The Q2 segment table

DXC reports three segments. Revenue and profit figures below are from the 10-Q's segment note, in millions of dollars, for the quarter ended September 30.

SegmentQ2 FY26 revenueQ2 FY27 revenueYoYQ2 FY27 profit (FY26)Margin FY27 (FY26)
Consulting & Engineering (CES)$1,255$1,213-3.3%$125 ($145)10.3% (11.6%)
Global Infrastructure (GIS)$1,586$1,427-10.0%$66 ($122)4.6% (7.7%)
Insurance Software & Services$320$394+23.1%$45 ($28)11.4% (8.8%)
Total$3,161$3,034-4.0%$236 ($295)Adj. EBIT 6.2% (8.0%)

Insurance was 13.0% of Q2 revenue ($394 million / $3,034 million) but 19.1% of total segment profit ($45 million / $236 million). Adjusted EBIT was $187 million, down 26.4%. Non-GAAP diluted EPS was $0.67, down 20.2%, and GAAP diluted EPS was $0.15. Insurance bookings rose 43.5%, but its book-to-bill ratio was 0.79x, meaning new awards trailed the revenue the unit recognized in the quarter.

The contract-modification caveat

The 23.1% growth rate needs an asterisk. The 10-Q states: "Organic revenue growth includes a favorable contract modification entered into during the second quarter of fiscal 2027." CFO Robert Del Bene said on the call that it was "a onetime contract modification in our insurance business, which was not anticipated in our guidance."

He also gave the underlying picture: "Excluding the modification, the underlying insurance revenue was consistent quarter-to-quarter with growth in recurring software revenue, offset by the wind down of a business process services contract that we wrap in the fourth quarter." Insurance revenue was $319 million in Q1. If underlying Q2 revenue was close to that, the modification added roughly $75 million ($394 million - $319 million). That figure is an implied estimate; DXC did not disclose the amount.

The 10-Q also records a one-time impairment of transition and transformation costs and a one-time acceleration of software amortization, both tied to "a customer contract modification" in the quarter, without naming the segment. The modification also lifted the insurance outlook. Del Bene said DXC raised its full-year insurance guide "from low single-digit to mid-single-digit revenue growth," and added that "there was no real offset" to the one-time benefit. He said the unit's SaaS business "grew at a strong double-digit rate in the quarter."

What management said about the sale

Fernandez opened the call by addressing the reports: "While I don't want to get into specifics, I can confirm that we are currently in ongoing discussions. As we have said previously, management and the Board are committed to exploring all avenues to create shareholder value." He added: "We do not intend to answer additional questions at this time."

When an analyst raised Guidewire's purchase of hyperexponential (covered in TTFY's Guidewire deal analysis), Fernandez said: "I'm not going to get into comments about ISB." He then described the unit's attributes in general terms rather than discussing the process. The new full-year guidance table shows a 0% revenue impact from acquisitions and divestitures, consistent with an outlook that does not assume a sale.

The guidance cut

Q2 beat DXC's own targets. The July guide called for revenue of $2.97 billion to $3.00 billion and non-GAAP EPS of about $0.55, against actual results of $3.03 billion and $0.67. The full-year outlook still came down. Fernandez attributed the cut to "sales performance in our core business that fell short of our expectations."

FY27 guidanceJuly 30, 2026October 29, 2026
Revenue$12.10B to $12.35B$11.91B to $11.98B
Organic revenue growth-5.0% to -3.0%-5.5% to -5.0%
Adjusted EBIT margin6.0% to 7.0%5.75% to 6.25%
Non-GAAP diluted EPS$2.40 to $2.90$2.25 to $2.50
Free cash flow~$685M~$600M

The revenue midpoint fell 2.3%, from $12.225 billion to $11.945 billion (arithmetic: $11.945 billion / $12.225 billion - 1). For Q3, DXC guided to revenue of about $2.98 billion, an adjusted EBIT margin of about 6.0% and non-GAAP EPS of about $0.55. By segment, management now expects a mid-single-digit revenue decline in CES and a high-single-digit decline in GIS for the year.

DXC without insurance: the arithmetic

The figures below simply subtract the reported insurance segment from DXC's reported totals. They are not pro forma figures. They ignore sale proceeds, interest savings, taxes and any shared costs now allocated to insurance that could stay with DXC. The 10-Q says DXC allocates real estate, IT and other shared corporate costs to segments by revenue or headcount.

  • Q2 revenue: CES plus GIS came to $2,640 million, against $2,841 million a year earlier, down 7.1% ($3,034M - $394M vs $3,161M - $320M). DXC's reported decline including insurance was 4.0%.
  • Q2 segment profit: $191 million versus $267 million, down 28.5%. The combined margin was 7.2%, against 9.4% a year earlier.
  • First half of fiscal 2027: revenue of $5,320 million versus $5,687 million, down 6.5%. Segment profit was $329 million versus $469 million, down 29.9%.
  • Q2 adjusted EBIT less insurance profit: $142 million ($187 million - $45 million), or 5.4% of $2,640 million. That is before any reassignment of corporate costs.
  • Fiscal 2026 (10-K): revenue without insurance would have been $11,365 million ($12,644 million - $1,279 million).

In short, the remaining DXC would be smaller, shrinking faster and running at a thinner margin, before counting what the cash from a sale could do. For more on how analysts are reacting to results like these, see TTFY's analyst calls page.

How the stock took the report

The 8-K was accepted at 4:17 p.m. ET on October 29, after the close. $DXC fell 5.3% that session, to $15.23 from $16.09, before the numbers were out. It slipped another 1.6% on October 30, to $14.98. It closed at $15.31 on November 10, 0.5% above the October 29 close ($15.31 / $15.23 - 1). Wider market context is on the Markets page.

Bull/Bear Verdict

Bull Case: Q2 beat DXC's own guidance on revenue and EPS. Insurance posted an 11.4% margin with double-digit SaaS growth, and management confirmed sale talks for a unit Reuters said could fetch about $2.4 billion.

Bear Case: The insurance jump leaned on a one-time modification, and the full-year guide was cut. Without insurance, Q2 revenue fell 7.1% and segment profit fell 28.5%, before any stranded costs.

FAQ

Did DXC confirm it is selling its insurance business?

DXC confirmed talks, not a sale. The Q2 release acknowledges "ongoing discussions regarding a possible sale of its insurance business," and no definitive agreement had been announced through November 10, 2026.

Why did DXC's insurance revenue jump 23.1%?

Mostly because of a one-time favorable contract modification signed in the quarter. The CFO said underlying insurance revenue was consistent with the prior quarter, when the unit reported $319 million.

Did DXC lower its guidance?

Yes. Fiscal 2027 revenue guidance fell to $11.91 billion to $11.98 billion, from $12.10 billion to $12.35 billion. Non-GAAP EPS guidance fell to $2.25 to $2.50, from $2.40 to $2.90.

How big would DXC be without insurance?

By simple subtraction, Q2 revenue would have been $2,640 million instead of $3,034 million, and fiscal 2026 revenue $11,365 million instead of $12,644 million.

Share X LinkedIn Email
Disclaimer: The information provided is for informational purposes only and is not intended as financial, legal, or tax advice. Trading around earnings involves significant risk and increased volatility. Past performance is not indicative of future results. No strategy can guarantee profits or protect against loss. Consult a professional advisor before acting on any information provided.

More in Earnings · Full archive